Compositions comprising hmg-coa reductase inhibitor
OwnerAndreas Meyer, Jorg Ogorka +1inventors
InventorsAndreas Meyer, Jorg Ogorka, Sabine Desset-Brethes
Life of this patent
Estimating the term…
Abstract
The present invention relates to pharmaceutical compositions for sustained release comprising as active ingredient an HMG-CoA reductase inhibitor or a pharmaceutically acceptable salt thereof, said composition comprising an inner phase (internal) and an outer phase (external), wherein at least the outer phase comprises at least one matrix former.
Claims24
A pharmaceutical composition for sustained release comprising as active ingredient an HMG-CoA reductase inhibitor or a pharmaceutically acceptable salt thereof, said composition comprising an inner phase (internal) and an outer phase (external), wherein at least the outer phase comprises at least one matrix former.
Dependencies are inferred from the claim text.